Targeted therapy to prevent progression of calcific aortic stenosis
- PMID: 15353511
- PMCID: PMC3951855
- DOI: 10.1161/01.CIR.0000140722.85490.EA
Targeted therapy to prevent progression of calcific aortic stenosis
Figures
Comment in
-
Letter regarding article by Rosenhek et al, "statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis".Circulation. 2005 May 3;111(17):e274-5; author reply e274-5. doi: 10.1161/01.CIR.0000163538.27480.03. Circulation. 2005. PMID: 15867188 No abstract available.
Comment on
-
Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis.Circulation. 2004 Sep 7;110(10):1291-5. doi: 10.1161/01.CIR.0000140723.15274.53. Epub 2004 Aug 30. Circulation. 2004. PMID: 15337704 Review.
References
-
- O'Brien KD, Reichenbach DD, Marcovina SM, et al. Apolipoproteins B, (a) and E accumulate in the morphologically early lesion of “degenerative” valvular aortic stenosis. Arterioscler Thromb. 1996;16:523–532. - PubMed
-
- Mohler ER, III, Gannon F, Reynolds C, et al. Bone formation and inflammation in cardiac valves. Circulation. 2001;103:1522–1528. - PubMed
-
- O'Brien KD, Shavelle DM, Caulfield MT, et al. Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation. 2002;106:2224–2230. - PubMed
-
- Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. J Am Coll Cardiol. 1997;29:630–634. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
